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1. INTRODUCTION {#jso24816-sec-0005}
===============

Post radical prostatectomy urinary incontinence (PPI) is an adverse effect that decreases quality of life.[1](#jso24816-bib-0001){ref-type="ref"} Given the long life expectancy after radical prostatectomy (RP) for localized prostate cancer, many men suffer from PPI for decades.[2](#jso24816-bib-0002){ref-type="ref"}, [3](#jso24816-bib-0003){ref-type="ref"}, [4](#jso24816-bib-0004){ref-type="ref"}, [5](#jso24816-bib-0005){ref-type="ref"} There are several treatment options for PPI including behavioral therapy, pelvic floor exercises, pharmacotherapy, injectable bulking agents, sling procedures, and compression devices, for example, artificial urethral sphincter (AUS) implants.[6](#jso24816-bib-0006){ref-type="ref"} PPI correction surgery, in particular AUS, is indicated to men with moderate‐to‐severe urinary incontinence not amenable to conservative treatment, although there is no consensus on the definition of moderate‐to‐severe urinary incontinence.[6](#jso24816-bib-0006){ref-type="ref"}, [7](#jso24816-bib-0007){ref-type="ref"} Moreover, sphincter implants are costly and have a high revision rate.[8](#jso24816-bib-0008){ref-type="ref"} Little is known about the proportion of men with severe PPI who receive correction surgery and how the use of PPI surgery varies among health care providers. The aim of this study was to assess the use of PPI surgery in a nationwide population‐based cohort and to investigate factors associated with PPI correction surgery.

2. METHODS {#jso24816-sec-0006}
==========

2.1. Study population {#jso24816-sec-0007}
---------------------

We performed a cohort study in the National Prostate Cancer Register (NPCR) of Sweden of men who had been diagnosed with prostate cancer between 1998 and 2012 and who had received RP as primary treatment.[9](#jso24816-bib-0009){ref-type="ref"}, [10](#jso24816-bib-0010){ref-type="ref"}, [11](#jso24816-bib-0011){ref-type="ref"} Since 1998, NPCR captures 98% of all incident prostate cancer cases in Sweden as compared with the Cancer Register, to which reporting is mandatory by law. NPCR contains detailed information on cancer characteristics and primary treatment. By use of the unique Swedish personal identity numbers, NPCR has been linked to other population‐based healthcare registers and demographic databases to form the Prostate Cancer data Base Sweden (PCBaSe).[9](#jso24816-bib-0009){ref-type="ref"} The Charlson Comorbidity Index (CCI) was calculated by the use of data on discharge diagnoses in the Patient Registry as previously described.[9](#jso24816-bib-0009){ref-type="ref"}, [12](#jso24816-bib-0012){ref-type="ref"}

Men who underwent PPI correction surgery were identified by use of the procedure code KDK00 in the NOMESCO Classification of Surgical Procedures (NCSP), version 1.16, in the Patient Registry. This code is intended to be used only for sphincter implants, but since there are no codes for other forms of PPI surgeries, such as sling procedures and non‐circumferential compression devices, this code was also used for other PPI surgeries. However, during the study period these alternative procedures were rarely performed in Sweden (personal communication RP and DV).

Information on educational level was retrieved from Longitudinal integration database for health insurance and labor market studies database (acronym in Swedish "LISA"). The educational level was categorized into low (\<10 years of education), intermediate (10‐12 years), and high (\>12 years).

Center volume of RP and PPI surgery was defined as the number of respective surgeries performed at that center in the preceding 365 days.

Since 2008, NPCR aims to distribute Patient Reported Outcome Measures (PROMs) questionnaires before and 1, 3, and 5 years after RP.[9](#jso24816-bib-0009){ref-type="ref"}, [13](#jso24816-bib-0013){ref-type="ref"} Severe urinary incontinence was defined at one year after RP with one of the following responses to the question "Do you have urinary leakage?": "I use pads all the time and they have to be changed because they are wet" or "I use pads all the time and they have to be changed continuously because they are wet."

2.2. Statistical analyses {#jso24816-sec-0008}
-------------------------

To assess the use of PPI correction surgery, these procedures were weighted by the number of RPs performed 2 years preceding date of PPI surgery.[14](#jso24816-bib-0014){ref-type="ref"} Cox proportional hazard regression models were used to estimate hazard ratios (HR) with 95% confidence intervals (CI) for the event PPI surgery in uni‐ and multivariable analysis. The variables in the analysis were: aggregated cancer risk category, age at RP, CCI, educational level, marital status, post‐operative radiotherapy, and center volume of RP and PPI surgery. Patients were considered at risk from the date of RP until PPI surgery, death, or the last follow‐up date, whichever occurred first.

3. RESULTS {#jso24816-sec-0009}
==========

In total, 26 280 men underwent RP as primary treatment for prostate cancer between 1998 and 2012. Of these, 782 (3%) men underwent PPI correction surgery after a median time of 3 years (IQR 1.8‐4.3) after RP (Table [1](#jso24816-tbl-0001){ref-type="table-wrap"}). There was an eightfold increase in PPI surgery during the study period, from less than 10 procedures per year in 2001 to 70‐80 procedures per year in 2009 and onwards. This rise occurred in parallel with an increase in the numbers of RP per year. The number of PPI surgeries per year per 1000 RPs performed two years preceding PPI surgery similarly increased from less than 10 procedures in 2001 to around 30 in 2009 and onwards (Figure [1](#jso24816-fig-0001){ref-type="fig"}). A quarter (196/782) of men who underwent PPI surgery had repeated procedures. RPs were performed in approximately 40 centers, whereas PPI surgery was performed in 18 centers. The majority (60%) of all PPI procedures were performed at three centers. A large proportion of men who underwent PPI surgery (39‐56%) at one of these three centers had received their RP at another center (Supplementary Figure S1).

###### 

Baseline characteristics for men diagnosed with prostate cancer from 1998 to 2012 in Prostate Cancer data Base Sweden (PCBaSe) 3.0 treated with radical prostatectomy (RP) stratified by receipt of post prostatectomy urinary incontinence (PPI) correction surgery

                                                                                  PPI surgery *n* (%)   All *n* (%)
  ------------------------------------------------------------------------------- --------------------- -------------
  Age at RP (years)                                                                                     
  Median (IQR)                                                                    64 (60‐68)            63 (59‐67)
  \<60                                                                            166 (21)              7410 (28)
  60‐64                                                                           256 (33)              8267 (31)
  65‐69                                                                           240 (31)              7814 (30)
  ≥70                                                                             120 (15)              2789 (11)
  Aggregated risk category[^a^](#jso24816-note-0003){ref-type="fn"}                                     
  Favorable‐risk                                                                  629 (80)              22 175 (84)
  Aggressive disease                                                              141 (18)              3745 (14)
  Missing                                                                         12 (2)                360 (1)
  Year of RP                                                                                            
  1998‐2000                                                                       56 (7)                1727 (7)
  2001‐2003                                                                       120 (15)              3474 (13)
  2004‐2006                                                                       240 (31)              6794 (26)
  2007‐2009                                                                       235 (30)              6762 (26)
  2010‐2012                                                                       131 (17)              7523 (29)
  Year of PPI correction surgery                                                                        
  2000‐2002                                                                       27 (3)                27 (3)
  2003‐2005                                                                       80 (10)               80 (10)
  2006‐2008                                                                       171 (22)              171 (22)
  2009‐2011                                                                       260 (33)              260 (33)
  2012‐2014                                                                       244 (31)              244 (31)
  Multiple PPI correction surgeries                                                                     
  No                                                                              586 (75)              
  Yes                                                                             196 (25)              
  Time to PPI correction surgery (years)                                                                
  Median (IQR)                                                                    2.8 (1.8‐4.3)         
  \<1 year                                                                        29 (4)                
  1‐2 years                                                                       204 (26)              
  2‐3 years                                                                       202 (26)              
  3‐4 years                                                                       118 (15)              
  \>4 years                                                                       229 (29)              
  Charlson comorbidity index                                                                            
  0                                                                               672 (86)              23 319 (89)
  1                                                                               74 (9)                1804 (7)
  2+                                                                              36 (5)                1157 (4)
  Marital status                                                                                        
  Married                                                                         593 (76)              19 362 (74)
  Not married                                                                     189 (24)              6904 (26)
  Missing                                                                         0 (0)                 14 (0)
  Education level[^b^](#jso24816-note-0004){ref-type="fn"}                                              
  High                                                                            212 (27)              8044 (31)
  Intermediate                                                                    329 (42)              10 784 (41)
  Low                                                                             238 (30)              7333 (28)
  Missing                                                                         3 (0)                 119 (0)
  RP center volume[^c^](#jso24816-note-0005){ref-type="fn"}                                             
  \<50                                                                            358 (46)              12 402 (47)
  50‐99                                                                           217 (28)              6619 (25)
  100+                                                                            207 (26)              7259 (28)
  PPI correction surgery center volume[^d^](#jso24816-note-0006){ref-type="fn"}                         
  \<10                                                                            684 (87)              23 165 (88)
  10‐15                                                                           37 (5)                1156 (4)
  \>15                                                                            61 (8)                1959 (7)

IQR, interquartile range.

PPI correction surgery defined by KDK00: diagnostic code for urinary incontinence surgery of the NOMESCO Classification of Surgical Procedures (NCSP), version 1.16.

Prostate cancer risk categories according to modified NCCN categorisation: Low‐risk = T1‐2, Prostate‐specific antigen (PSA) \<10 ng/mL and Gleason score (GS) ≤6; Intermediate‐risk = T1‐2, PSA \<20 ng/mL and PSA 10‐19.9 ng/mL or GS 7; High‐risk = T1 2, PSA \<50 ng/mL with GS 8 10 or PSA 20‐49.9 ng/mL; Locally advanced = T3 and PSA \<50 ng/mL; Regionally metastatic = PSA \<100 ng/mL with T4 or PSA 50‐99.9 ng/mL or N1; Distant metastases = PSA ≥100 ng/mL or M1. Aggregated risk categories: favorable‐risk included low‐risk and intermediate‐risk cancer; aggressive disease included high‐risk, locally advanced, regionally metastatic, and distant metastases.

Education level is low: \<10 years of education; middle: 10‐12 years; high: \>12 years.

RP center volume: number of RPs performed at a center in the year before the RP in this study.

PPI surgery center volume the number of PPI surgeries performed in the year before the study RP.

© 2017 Wiley Periodicals, Inc.

![Numbers of post prostatectomy urinary incontinence (PPI) correction surgery per year and PPI correction surgery per 1000 radical prostatectomies performed during 2 preceding years. RP: radical prostatectomy](JSO-117-321-g001){#jso24816-fig-0001}

Patient characteristics associated with risk of PPI surgery included old age at RP: \>70 years versus \<60, HR 1.96 (1.54‐2.50); moderate comorbidity: CCI = 1 versus 0, HR 1.36 (1.06‐1.73); and aggressive prostate cancer versus favorable‐risk: HR 1.29 (1.07‐1.55). RP at a high‐volume RP center was associated with a lower risk of a subsequent PPI procedure: \>100 RPs/year versus \<50 RPs/year, HR 0.81 (0.66‐0.99) (Table [2](#jso24816-tbl-0002){ref-type="table-wrap"}), whereas, having RP at a high‐volume PPI surgery center was associated with a higher likelihood of PPI surgery: \>15 PPI procedures/year versus \<10 PPI procedures/year, HR 1.71 (1.27‐2.30).

###### 

Hazard ratios (HR) and 95% confidence intervals (CI) for post prostatectomy urinary incontinence (PPI) correction surgery

                                                                                                 Univariable analysis   Multivariable analysis          
  ------------------------------------------------------------------------------- -------------- ---------------------- ------------------------ ------ -----------
  Age at RP (years)                                                                                                                                     
  \<60                                                                            7299 (165)     1.00                   (Ref.)                   1.00   (Ref.)
  60‐64                                                                           8128 (254)     1.41                   1.16‐1.72                1.37   1.13‐1.67
  65‐69                                                                           7674 (233)     1.43                   1.17‐1.75                1.37   1.12‐1.67
  ≥70                                                                             2700 (115)     2.13                   1.68‐2.70                1.96   1.54‐2.50
  Charlson comorbidity index                                                                                                                            
  0                                                                               22 954 (658)   1.00                   (Ref.)                   1.00   (Ref.)
  1                                                                               1792 (73)      1.46                   1.15‐1.86                1.36   1.06‐1.73
  2+                                                                              1055 (36)      1.30                   0.93‐1.82                1.19   0.85‐1.67
  Aggregated risk category[^a^](#jso24816-note-0008){ref-type="fn"}                                                                                     
  Favorable‐risk                                                                  22 080 (627)   1.00                   (Ref.)                   1.00   (Ref.)
  Aggressive disease                                                              3721 (140)     1.39                   1.15‐1.66                1.29   1.07‐1.55
  Post‐operative radiotherapy                                                                                                                           
  No                                                                              23 750 (697)   1.00                   (Ref.)                   1.00   (Ref.)
  Yes                                                                             2051 (70)      1.19                   0.93‐1.52                1.08   0.84‐1.39
  RP center volume[^b^](#jso24816-note-0009){ref-type="fn"}                                                                                             
  \<50                                                                            12 199 (380)   1.00                   (Ref.)                   1.00   (Ref.)
  50‐99                                                                           6529 (207)     1.13                   0.95‐1.33                1.07   0.90‐1.27
  \>100                                                                           7073 (180)     0.91                   0.76‐1.08                0.81   0.66‐0.99
  PPI correction surgery center volume[^c^](#jso24816-note-0010){ref-type="fn"}                                                                         
  \<10                                                                            22 796 (675)   1.00                   (Ref.)                   1.00   (Ref.)
  10‐15                                                                           1093 (34)      1.18                   0.83‐1.66                1.42   0.99‐2.05
  \>15                                                                            1912 (58)      1.42                   1.08‐1.86                1.71   1.27‐2.30
  Education level[^d^](#jso24816-note-0011){ref-type="fn"}                                                                                              
  Low                                                                             7240 (237)     1.00                   (Ref.)                   1.00   (Ref.)
  Intermediate                                                                    10 637 (322)   0.95                   0.80‐1.12                0.99   0.84‐1.17
  High                                                                            7924 (208)     0.83                   0.69‐0.99                0.86   0.71‐1.04
  Marital status                                                                                                                                        
  Married                                                                         19 044 (581)   1.00                   (Ref.)                   1.00   (Ref.)
  Not married                                                                     6757 (186)     0.93                   0.79‐1.10                0.95   0.81‐1.12

PPI correction surgery defined by KDK00: diagnostic code for urinary incontinence surgery of the NOMESCO Classification of Surgical Procedures (NCSP), version 1.16.

Prostate cancer risk categories according to modified NCCN categorisation: Low‐risk = T1‐2, Prostate‐specific antigen (PSA) \<10 ng/mL and Gleason score (GS) ≤6; Intermediate‐risk = T1‐2, PSA \<20 ng/mL and PSA 10‐19.9 ng/mL or GS 7; High‐risk = T1 2, PSA \<50 ng/mL with GS 8 10 or PSA 20‐49.9 ng/mL; Locally advanced = T3 and PSA \<50 ng/mL; Regionally metastatic = PSA \<100 ng/mL with T4 or PSA 50‐99.9 ng/mL or N1; Distant metastases = PSA ≥100 ng/mL or M1.

RP center volume: number of RPs performed at a center in the year before the RP in this study.

PPI correction surgery center volume the number of PPI surgeries performed in the year before the study RP.

Educational level is low: \<10 years of education; middle: 10‐12 years; high: \>12 years. Aggregated risk categories: favorable‐risk included low‐risk and intermediate‐risk cancer; aggressive disease included high‐risk, locally advanced, regionally metastatic, and distant metastases.

© 2017 Wiley Periodicals, Inc.

There was an up to 10‐fold crude (Figure [2](#jso24816-fig-0002){ref-type="fig"}) and adjusted variation between counties in the use of PPI surgery: from HR 0.29 (95%CI 0.09‐0.92) to HR 3.44 (2.50‐4.73), with the most populous county (Stockholm) as reference (Figure [3](#jso24816-fig-0003){ref-type="fig"}).

![Proportion of men who underwent a post prostatectomy urinary incontinence (PPI) correction surgery per county of residence. A (since 2011), B, N, O, P, R, and U are counties with a university hospital](JSO-117-321-g002){#jso24816-fig-0002}

![Multivariable adjusted hazard rations (HRs) and 95% confidence intervals (Cis) for receipt of post prostatectomy urinary incontinence correction surgery according to the county of residence. Model adjusted for: age at RP, CCI, education, marital status, RP center volume, PPI surgery centere volume, risk category, post‐operative radiotherapy. At risk: number of RPs. Events: number of PPI correction surgery. PPI correction surgery = KDK00, diagnostic code for urinary incontinence surgery of the NOMESCO Classification of Surgical Procedures (NCSP), version 1.16. Educational level is low: \<10 years of education; middle: 10‐12 years; high: \>12 years. Favorable‐risk includes low‐risk and intermediate‐risk cancer. Aggressive disease includes high‐risk, locally advanced, regionally metastatic, and distant metastases. Prostate cancer risk categories according to modified NCCN categorisation: Low‐risk = T1‐2, Prostate‐specific antigen (PSA) \<10 ng/mL and Gleason score (GS) ≤6; Intermediate‐risk = T1‐2, PSA \<20 ng/mL and PSA 10‐19.9 ng/mL or GS 7; High‐risk = T1 2, PSA \<50 ng/mL with GS 8 10 or PSA 20‐49.9 ng/mL; Locally advanced = T3 and PSA \<50 ng/mL; Regionally metastatic = PSA \<100 ng/mL with T4 or PSA 50‐99.9 ng/mL or N1; Distant metastases = PSA ≥100 ng/mL or M1. RP center volume: number of RPs performed at a center in the year before the RP in this study. PPI correction surgery center volume the number of PPI correction surgeries performed in the year before the study RP. \*\*County with a university hospital](JSO-117-321-g003){#jso24816-fig-0003}

PROM data at 12 months after RP were available for a subgroup of 2876 men and severe incontinence was reported by 215 (7%) of these men. Out of these, 51/215 (24%) had a PPI procedure at a median time of 2.3 years (IQR 2‐2.8) after RP (Supplementary Table S1).

Use of PPI surgery was higher after RP at a PPI surgery center compared with RPs performed at a center not performing PPI surgery 155/6209 (2.5%) versus 280/17 299 (1.6%), *P* \< 0.001 despite the fact that severe PPI at PROM was equally common after RPs performed at PPI surgery centers compared with centers not performing PPI surgery, 84/1250 (6.7%) versus 131/1626 (8.1%), *P* = 0.20 (Supplementary Table S2).

4. DISCUSSION {#jso24816-sec-0010}
=============

In this population‐based, nationwide study in Sweden, 3% of men who underwent RP subsequently received PPI correction surgery, with an increase between 2000 and 2014 in parallel to the increase in the number of RPs. Use of PPI surgery varied up to 10‐fold between counties, and only a quarter of men with severe PPI on PROM underwent PPI surgery, suggesting that PPI surgery was underutilized.

The main limitation of this study is the use of administrative data for defining the end‐point. However, since the reimbursement to the departments performing surgery is based on the number of procedures reported to the National Patient Register, this register captures virtually all in‐patient surgical procedures.[15](#jso24816-bib-0015){ref-type="ref"} Strengths of our study include the use of comprehensive data in nationwide population‐based health care registers with high quality and a virtually complete capture of cases and treatments with less than 1% loss of men during follow‐up.[11](#jso24816-bib-0011){ref-type="ref"}, [16](#jso24816-bib-0016){ref-type="ref"} PROM data allowed us to assess the proportion of men with self‐reported severe incontinence that received corrective surgery for PPI.

Overall, 3% of men who underwent RP subsequently had PPI surgery, indicating that severe urinary incontinence cannot be regarded as a "rare adverse event."[17](#jso24816-bib-0017){ref-type="ref"} There are several possible explanations for the increase in use of PPI surgery during the study period. Active surveillance became more common, which reduced the number of RPs performed in men with low‐risk prostate cancer who have a lower risk of PPI[18](#jso24816-bib-0018){ref-type="ref"} and the proportion of men with low‐risk prostate cancer among men who underwent RP decreased from 47% in 1998‐2003 to 34% in 2010‐2012, whereas, the proportion of men with pT3 disease increased from 14% in 2007 to 33% in 2012. Most likely, vigilance for severe PPI and willingness to perform PPI surgery for urinary incontinence increased during the study period.

The proportion of men who had multiple PPI surgeries 196/782 (25%) in our study are in agreement with previous reports.[8](#jso24816-bib-0008){ref-type="ref"} Old age, moderate comorbidity, and aggressive cancer were associated with an increased use of PPI surgery, also in accordance with previous studies.[19](#jso24816-bib-0019){ref-type="ref"}, [20](#jso24816-bib-0020){ref-type="ref"}, [21](#jso24816-bib-0021){ref-type="ref"}

There was up to ten‐fold difference in use of PPI surgery between counties, despite equal access within the tax‐financed Swedish health care system. To the best our knowledge there is no previous report on differences in use of PPI surgery between health care providers. After adjustment for confounders, RP at a high‐volume center was associated with a significantly decreased risk of PPI surgery. Moreover, PPI surgery was more common in men who had RP at a center where PPI surgery was performed, despite a similar rate of patient reported incontinence, suggesting that PPI is particularly underutilized among men who have RP at centers where PPI surgery is not performed. Our results indicate that the health care provider is more important than patient characteristics in determining if a man with severe PPI receive correction surgery.

The proportion of men in our study who underwent PPI surgery is essentially in accordance with previous reports on the use of PPI correction surgery.[22](#jso24816-bib-0022){ref-type="ref"}, [23](#jso24816-bib-0023){ref-type="ref"}, [24](#jso24816-bib-0024){ref-type="ref"}, [25](#jso24816-bib-0025){ref-type="ref"} In the Ontario Health Insurance Plan Register, 3% of men who had undergone RP had received a PPI surgery within a median time of 3 years after RP.[23](#jso24816-bib-0023){ref-type="ref"} Based on sale number for AUS by AMS in 2005 combined with the number of RPs performed in 2003 in the US, 6% of men who had undergone RP were estimated to have received an AUS.[14](#jso24816-bib-0014){ref-type="ref"} This calculation was based on the assumption that there was 2‐year delay from RP to implant of sphincter device and that the number of devices represented a primary procedure. According to data in SEER Medicare,[22](#jso24816-bib-0022){ref-type="ref"} 6% of men who underwent RP from 2007 to 2010 received a PPI procedure after a median time of 20 months. We observed an eightfold increase in the number of PPI procedure during the study period. A similar increase was observed in a study based on the English Hospital Episode Statistics database[24](#jso24816-bib-0024){ref-type="ref"} and in a study based on case log data of US certified urologists.[25](#jso24816-bib-0025){ref-type="ref"} To the best of our knowledge, our report is the first to assess the proportion of men with severe urinary incontinence according to self‐reported PROM who received PPI surgery.

5. CONCLUSION {#jso24816-sec-0011}
=============

In this nationwide population‐based study, 3% of men who had undergone RP subsequently received PPI correction surgery. There was an up to 10‐fold difference in the use of PPI surgery between health care providers. Only a quarter of men with severe urinary incontinence on PROM underwent PPI surgery, suggesting that PPI surgery remains underutilized.
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###### 

**Figure S1**. Number of post prostatectomy urinary incontinence (PPI) correction surgery by center in Sweden and year of procedure.

**Table S1**. Baseline characteristics for men treated with radical prostatectomy (RP) for prostate cancer from 2007 to 2012 in Prostate Cancer data Base Sweden 3.0 who had filled a questionnaire for Patient Reported Outcome Measures.

**Table S2**. Proportion of men with severe post prostatectomy urinary incontinence (PPI) and proportion of men who received a PPI correction surgery within 3 years after RP according to radical prostatectomy performed or not in a PPI correction surgery center.

###### 

Click here for additional data file.
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